| Old Articles: <Older 2151-2160 Newer> |
|---|
 |
InternetNews
July 1, 2005
Roy Mark |
Senators Prescribe Health IT Legislation Bill explores ways to apply latest information technology to nation's health records.   |
BusinessWeek
July 11, 2005
Timothy J. Mullaney |
Cisco: Paging Dr. Info Tech Cisco Systems Inc.'s medical director is backing a plan in which big companies such as Cisco will give doctors financial incentives to adopt technology, with the goal of cutting costs and improving care. This plan is to put Silicon Valley in the vanguard of health-care reform. |
The Motley Fool
June 30, 2005
Brian Gorman |
Teva's Non-Generic Side The drug company is working hard to cement its position in the market for multiple sclerosis meds. Investors, take note. |
The Motley Fool
June 30, 2005
Tom Taulli |
The Scrushy Defense PR, highly paid attorneys, and ignorance: A recipe that worked quite well for HealthSouth's former CEO. The company currently trades on the Pink Sheets at around $5.80 per share. |
The Motley Fool
June 30, 2005
Stephen D. Simpson |
Biomet Wants Your Body Steady growth continues at the #4 orthopedics player. But Biomet shares haven't had a great year so far, hovering close to their 52-week low. |
The Motley Fool
June 30, 2005
Brian Gorman |
The Co-Pay Effect Higher co-payments look like the wave of the future, and investors should expect the trend to boost major generic players like Teva Pharmaceutical, Mylan Laboratories, and Novartis. |
Pharmaceutical Executive
June 1, 2005
Boschwitz et al. |
Track Patients, Not Prescriptions Why pharma companies reject anonymous patient-level data, and why they can't do without it for long. |
Pharmaceutical Executive
June 1, 2005
Jan Malek |
When Two Heads are Better R&D president isn't one job-it's two. By appointing COOs for R&D with broad operational mandates, biotech and pharmaceutical companies can ensure that operational issues get the attention they urgently require. |
Pharmaceutical Executive
June 1, 2005
Peter J. Pitts |
Opinion: Uncle Sam, MD Is having the government pursue a patent the best way of placing important discoveries in the public domain? It depends. Is putting the government in control of drug development in the best interests of public health? No. |
The Motley Fool
June 29, 2005
Stephen D. Simpson |
Medtronic Makes a Fat Deal Medtronic's purchase of the developer of an "obesity pacemaker" could reap rewards in a few years. Investors, take note. |
| <Older 2151-2160 Newer> Return to current articles. |
